Alberto Ocana
Alberto Ocana
Unit Head. Experimental Therapeutics. Hospital Clínico San Carlos. Madrid. Director Translational
Потвърден имейл адрес: sescam.jccm.es - Начална страница
ЗаглавиеПозоваванияГодина
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ...
JNCI: Journal of the National Cancer Institute 106 (6), 2014
11072014
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer
M Scaltriti, F Rojo, A Ocaña, J Anido, M Guzman, J Cortes, S Di Cosimo, ...
Journal of the National Cancer Institute 99 (8), 628-638, 2007
8142007
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
A Bruna, RS Darken, F Rojo, A Ocaña, S Peñuelas, A Arias, R Paris, ...
Cancer cell 11 (2), 147-160, 2007
4502007
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
E Amir, B Seruga, S Niraula, L Carlsson, A Ocaña
Journal of the National Cancer Institute 103 (17), 1299-1309, 2011
4152011
Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, O Ace, MG McNamara, M Al-Mubarak, FE Vera-Badillo, ...
Cancer Epidemiology and Prevention Biomarkers 23 (7), 1204-1212, 2014
2962014
Drug resistance in metastatic castration-resistant prostate cancer
B Seruga, A Ocana, IF Tannock
Nature reviews Clinical oncology 8 (1), 12, 2011
2832011
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ...
Journal of the National Cancer Institute 106 (1), djt319, 2013
2282013
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors
JC Montero, S Seoane, A Ocaña, A Pandiella
Clinical cancer research 17 (17), 5546-5552, 2011
2032011
Preclinical development of molecular-targeted agents for cancer
A Ocana, A Pandiella, LL Siu, IF Tannock
Nature reviews Clinical oncology 8 (4), 200, 2011
1862011
The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs
S Niraula, B Seruga, A Ocana, T Shao, R Goldstein, IF Tannock, E Amir
Journal of Clinical Oncology 30 (24), 3012-3019, 2012
1562012
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
S Niraula, A Ocana, M Ennis, PJ Goodwin
Breast cancer research and treatment 134 (2), 769-781, 2012
1512012
HER3 overexpression and survival in solid tumors: a meta-analysis
A Ocana, F Vera-Badillo, B Seruga, A Templeton, A Pandiella, E Amir
JNCI: Journal of the National Cancer Institute 105 (4), 266-273, 2012
1452012
When are “positive” clinical trials in oncology truly positive?
A Ocana, IF Tannock
Journal of the National Cancer Institute 103 (1), 16-20, 2010
1212010
Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
M Yu, A Ocana, IF Tannock
Cancer and Metastasis Reviews 32 (1-2), 211-227, 2013
1142013
Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target
JC Montero, A Ocana, M Abad, MJ Ortiz-Ruiz, A Pandiella, ...
PloS one 4 (5), e5565, 2009
1142009
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis
A Ocana, F Vera-Badillo, M Al-Mubarak, AJ Templeton, ...
PloS one 9 (4), e95219, 2014
1092014
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer
FE Vera-Badillo, R Shapiro, A Ocana, E Amir, IF Tannock
Annals of oncology 24 (5), 1238-1244, 2013
1082013
Neuregulins and cancer
JC Montero, R Rodríguez-Barrueco, A Ocaña, E Díaz-Rodríguez, ...
Clinical cancer research 14 (11), 3237-3241, 2008
1032008
Systemic therapy for non–clear cell renal cell carcinomas: a systematic review and meta-analysis
FE Vera-Badillo, AJ Templeton, I Duran, A Ocana, P de Gouveia, P Aneja, ...
European urology 67 (4), 740-749, 2015
1002015
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy
AM Gonzalez-Angulo, SE McGuire, TA Buchholz, SL Tucker, HM Kuerer, ...
J Clin Oncol 23 (28), 7098-7104, 2005
952005
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20